Replies to post #119109 on Biotech Values

[DewDiligence]

PRGO submits ANDA for ABT’s Androgel:

http://finance.yahoo.com/news/Perrigo-Confirms-Filing-for-prnews-3109803766.html?x=0&.v=1

ABT acquired Androgel in the Sep 2009 buyout of Solvay’s pharma business. The PRGO PR above says Androgel sells $900M annually; however, the US sales, which are what PRGO is chasing, are less than that.